Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-099161
Filing Date
2025-07-28
Accepted
2025-07-28 16:08:19
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20250630.htm   iXBRL 10-Q 2916623
2 EX-10.1 dyn-ex10_1.htm EX-10.1 1149929
3 EX-31.1 dyn-ex31_1.htm EX-31.1 13434
4 EX-31.2 dyn-ex31_2.htm EX-31.2 12864
5 EX-32.1 dyn-ex32_1.htm EX-32.1 7222
6 EX-32.2 dyn-ex32_2.htm EX-32.2 7041
  Complete submission text file 0000950170-25-099161.txt   10396644

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20250630.xsd EX-101.SCH 982819
66 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20250630_htm.xml XML 1613079
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 251155628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)